Your browser doesn't support javascript.
loading
Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
Gevaert, Philippe; Mullol, Joaquim; Saenz, Rebecca; Ko, Jinnie; Steinke, John W; Millette, Lauren A; Meltzer, Eli O.
Afiliação
  • Gevaert P; Upper Airway Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.
  • Mullol J; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic, The August Pi i Sunyer Biomedical Research Institute, Universitat de Barcelona, Centro de Investigación Biomédica en Red Instituto de Salud, Madrid, Spain.
  • Saenz R; Genentech, Inc., South San Francisco, California.
  • Ko J; Genentech, Inc., South San Francisco, California.
  • Steinke JW; Genentech, Inc., South San Francisco, California.
  • Millette LA; Genentech, Inc., South San Francisco, California. Electronic address: millette.lauren@gene.com.
  • Meltzer EO; Division of Allergy and Immunology, University of California, San Diego, La Jolla, California.
Ann Allergy Asthma Immunol ; 132(3): 355-362.e1, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37951571
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Rinite / Pólipos Nasais / Rinossinusite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Sinusite / Rinite / Pólipos Nasais / Rinossinusite Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article